Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2011-05-20FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC to update the product labeling…
-
FDA approval · 2011-05-20FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for Omeprazole and Sodium Bicarbonate from Oceanside Pharmaceuticals, updating the labeling to refle…
-
FDA approval · 2011-05-20FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Dexilant (dexlansoprazole) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Safety of Rabeprazole in Patients Under Multiple Treatments
A terminated clinical trial evaluating the safety of rabeprazole in patients receiving multiple concomitant treatments for gastroesophageal …
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Influence of Hygiene-dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With Rabeprazol
A clinical trial investigating the influence of hygiene-dietary habits and treatment adherence on the effectiveness of rabeprazole for gastr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms. [Phase 3]
An open-label Phase 3 study evaluated different dosing regimens of rabeprazole in GERD patients with night-time heartburn; the trial status …
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia. [Phase 3]
A Phase 3 trial evaluating whether Rozerem (ramelteon) influences the perception of gastroesophageal reflux symptoms in patients with chroni…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Prescription Methods Assessment Project (PMAP) [NA]
The Prescription Methods Assessment Project (PMAP) clinical trial conducted by the American Academy of Family Physicians has been terminated…
-
CLINICAL_TRIALS trial_result · 2011-04-29Clinical Trial Update: Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy [Phase 3]
Phase 3 trial evaluating dexlansoprazole MR for heartburn control in GERD patients previously on twice-daily PPI therapy. The study has comp…
-
CLINICAL_TRIALS trial_result · 2011-04-25Clinical Trial Update: Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI [Phase 2]
Phase 2 trial evaluating multiple doses of lesogaberan (AZD3355) added to proton pump inhibitor therapy in GERD patients with partial respon…
-
CLINICAL_TRIALS trial_result · 2011-04-11Clinical Trial Update: A Study on the Effectiveness of Laparoscopic Fundoplication on Extraesophageal Manifestations of Gastroesophageal Reflux Disease (GERD) [NA]
A completed clinical trial evaluating the effectiveness of laparoscopic fundoplication for extraesophageal manifestations of GERD.
-
FDA approval · 2011-04-07FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Dexilant (lansoprazole) from Takeda Pharmaceuticals America, Inc., updating its labeling to …
-
CLINICAL_TRIALS research · 2011-04-06Clinical Trial Update: A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux Disease(GERD) in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece
A completed cross-sectional study conducted in Greece evaluated the prevalence of gastroesophageal reflux disease among patients with upper …
-
CLINICAL_TRIALS research · 2011-03-31Clinical Trial Update: Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in Thailand
This update summarizes a completed clinical trial examining the prevalence of gastroesophageal reflux disease (GERD) among patients with upp…
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: Laparoscopic Antireflux Surgery Versus Endoscopic Full-thickness Gastroplication for Gastroesophageal Reflux Disease (GERD) [NA]
This clinical trial compared laparoscopic antireflux surgery with endoscopic full-thickness gastroplication for gastroesophageal reflux dise…
-
CLINICAL_TRIALS trial_result · 2011-03-23Clinical Trial Update: Laparoscopic Nissen Versus Toupet Fundoplication: Objective and Subjective Results of a Prospective Randomized Trial [NA]
This completed randomized trial compares laparoscopic Nissen fundoplication versus Toupet fundoplication for gastroesophageal reflux disease…
-
CLINICAL_TRIALS research · 2011-03-08Clinical Trial Update: Serial Exhaled Breath pH Monitoring
A University of Virginia-sponsored clinical trial investigates serial exhaled breath pH monitoring for gastroesophageal reflux disease; the …
-
CLINICAL_TRIALS trial_result · 2011-03-04Clinical Trial Update: Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP [NA]
A completed clinical trial evaluating the use of esomeprazole as a diagnostic test for gastroesophageal reflux disease in patients with non-…
-
FDA approval · 2011-02-28FDA Approved: METOCLOPRAMIDE — Supplemental Application (Genus Lifesciences Inc.)
FDA approved Genus Lifesciences' supplemental application for metoclopramide hydrochloride (metoclopramide), authorizing its generic product…
-
FDA approval · 2011-02-25FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
The FDA approved a supplemental application for Prilosec OTC (omeprazole magnesium) to support its over‑the‑counter labeling and use. This a…
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: Survey Examining the Frequency and Severity of Acid Related Symptoms While Taking Nexium
A completed clinical trial update that examined how often and how severely patients taking Nexium (esomeprazole) experience acid-related sym…
-
CLINICAL_TRIALS trial_result · 2011-02-07Clinical Trial Update: Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France
A completed clinical trial in France evaluating the societal costs and patient burden associated with partial response to proton pump inhibi…
-
CLINICAL_TRIALS trial_result · 2011-01-31Clinical Trial Update: A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms
A completed study evaluated use patterns and safety of rabeprazole sodium in simulated over-the-counter use for heartburn symptoms.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously [Phase 4]
A Phase 4 open, randomized two-way crossover trial in gastroesophageal reflux disease evaluating 40 mg doses given orally and intravenously;…
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD) [Phase 4]
Phase 4 study comparing 20 mg esomeprazole given orally versus intravenously (15-minute infusion) and their effects on basal and pentagastri…